Source: European Medicines Agency (EU) Revision Year: 2005 Publisher: Pfizer Inc. - G.D. Searle LLC
Maxaquin – Lomefloxacin hydrochloride tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. |
Maxaquin is available as a film-coated tablet formulation containing 400 mg of
lomefloxacin base, present as the hydrochloride salt. The base content of the
hydrochloride salt is 90.6%.
| Active Ingredient | Description | |
|---|---|---|
| Lomefloxacin |
Lomefloxacin is a synthetic broad-spectrum antimicrobial agent for oral administration. Lomefloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. |
| List of Excipients |
|---|
|
The inactive ingredients are carboxymethylcellulose calcium, hydroxypropyl cellulose, hypromellose, lactose, magnesium stearate, polyethylene glycol, polyoxyl 40 stearate, and titanium dioxide. |
Maxaquin (lomefloxacin HCl) is supplied as a scored, filmcoated tablet containing
the equivalent of 400 mg of lomefloxacin base present as the hydrochloride. The tablet is oval, white, and film-coated with “MAXAQUIN 400” debossed on one side and scored on the other side and is supplied in:
| NDC Number | Size |
|---|---|
| 0025-5501-01 | bottle of 20 |
Store at 59° to 77°F (15° to 25°C).
Pfizer Inc. - G.D. Searle LLC
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
